Zurich Cantonal Bank
PTGX icon

Zurich Cantonal Bank’s Protagonist Therapeutics PTGX Stock Holding History

Zurich Cantonal Bank’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
20,934
+7,522
+56% +$786K ﹤0.01% 992
2026
Q1 		$1.41M Buy
13,412
+3,339
+33% +$296K ﹤0.01% 1229
2025
Q4 		$880K Hold
10,073
– – ﹤0.01% 1420
2025
Q3 		$669K Hold
10,073
– – ﹤0.01% 1555
2025
Q2 		$557K Buy
10,073
+981
+11% +$47.1K ﹤0.01% 1588
2025
Q1 		$440K Sell
9,092
-610
-6% -$25.6K ﹤0.01% 1676
2024
Q4 		$374K Sell
9,702
-126
-1% -$5.49K ﹤0.01% 1802
2024
Q3 		$442K Sell
9,828
-16
-0.2% -$646 ﹤0.01% 1634
2024
Q2 		$341K Sell
9,844
-19
-0.2% -$556 ﹤0.01% 1757
2024
Q1 		$285K Sell
9,863
-475
-5% -$12.9K ﹤0.01% 1842
2023
Q4 		$237K Buy
10,338
+1,093
+12% +$19.1K ﹤0.01% 1987
2023
Q3 		$154K Sell
9,245
-465
-5% -$9.02K ﹤0.01% 2129
2023
Q2 		$268K Sell
9,710
-450
-4% -$11.3K ﹤0.01% 1725
2023
Q1 		$234K Buy
10,160
+1,624
+19% +$27.3K ﹤0.01% 1774
2022
Q4 		$93.1K Buy
8,536
+1,337
+19% +$11.3K ﹤0.01% 2317
2022
Q3 		$61K Hold
7,199
– – ﹤0.01% 2521
2022
Q2 		$57K Hold
7,199
– – ﹤0.01% 2537
2022
Q1 		$170K Buy
7,199
+906
+14% +$25.5K ﹤0.01% 1992
2021
Q4 		$215K Buy
6,293
+3,864
+159% +$122K ﹤0.01% 2020
2021
Q3 		$43K Buy
+2,429
New +$104K ﹤0.01% 2656

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Zurich Cantonal Bank's PTGX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Protagonist Therapeutics (PTGX) stake by 56% in Q2 2026, buying an estimated $786K and bringing the position to 20,934 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #992.

Zurich Cantonal Bank first reported a position in PTGX in Q3 2021 and has held it in 20 quarters since. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Zurich Cantonal Bank held 20,934 shares of Protagonist Therapeutics worth $2.57M as of Q2 2026.
  • Zurich Cantonal Bank bought 7,522 Protagonist Therapeutics shares in Q2 2026, an estimated $786K.
  • Protagonist Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #992 holding.
  • Zurich Cantonal Bank first reported a position in Protagonist Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.